Laurel Habel to Adenocarcinoma
This is a "connection" page, showing publications Laurel Habel has written about Adenocarcinoma.
Connection Strength
1.303
-
TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma. JCO Precis Oncol. 2023 05; 7:e2200570.
Score: 0.770
-
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis. 2002 Mar; 23(3):419-24.
Score: 0.178
-
Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Cancer Epidemiol Biomarkers Prev. 2001 Jan; 10(1):75-8.
Score: 0.164
-
Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
Score: 0.059
-
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
Score: 0.044
-
Barbiturates and lung cancer: a re-evaluation. Int J Epidemiol. 1999 Jun; 28(3):375-9.
Score: 0.037
-
Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
Score: 0.018
-
Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
Score: 0.017
-
Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
Score: 0.016